Cetek Corporation

Drug Discovery Platform • CE High Throughput Screening • Proprietary Drug Source & ChemSelect

Drug Discovery Platform

Growing Opportunities in Drug Discovery and Development. Cetek’s Drug Discovery Technologies.

Cetek’s drug discovery technologies are built around the ability to interface the CE AssayTM with multiple drug sources and/or Cetek’s drug source with conventional screening assays. Cetek is highly experienced in integrating its proprietary natural product-based drug sources and the CE Assay for high throughput screening against many challenging targets. The company’s approach capitalizes on the current and emerging opportunities for important new compounds in drug discovery and development. There is high need and interest in chemical diversity from nature and Cetek’s CE Assay is particularly suited to accessing natural sources for drug discovery. Underlying this interest is a sustained need for novel leads, increasing recognition that many newer and desirable targets require the types of chemistry and compounds not accessible with synthetic methods. In addition, innovative approaches and technologies are emerging to generate and access natural product-inspired diversity that is amenable to modern drug discovery methods. These approaches have solved challenges that previously slowed progress in the area.

Cetek’s core proprietary technologies and know-how are enhanced by expertise in natural product chemistry, chemical biology, drug target assay development, and medicinal chemistry. Cetek has integrated the CE Assay with complementary technologies to establish a productive drug discovery and development organization. The company's technologies include excellent proprietary natural product drug sources as a well as protein expression, natural product chemistry, and medicinal chemistry. Cetek has significant expertise in engineering, automation and informatics. With this expertise, the company has industrialized many aspects of the drug discovery process. The result is cost and time savings to drug leads and clinical candidates not otherwise accessible.

The company is applying its drug discovery technologies to build a pipeline of drug candidates in cancer. Cetek is also leveraging its drug discovery technologies through discovery services and collaborations.

Cetek is uniquely positioned to address the unmet and growing needs of biopharmaceutical companies with this its powerful technology and expertise.

A growing pipeline of novel compounds for cancer
Integrated, high throughput approach to discovering novel leads for compounds that modulate biological pathways in important disease areas.
Advantage for use with promising targets which have emerged from genomics and proteomics that have to date proven challenging for traditional screening technologies and for synthetic compounds.
Expanded drug discovery capability through an emerging, single compound library that combines the diversity inherent in natural products with the facility of synthetic chemistry.

Cetek Corporation • 508-229-8900 • info@cetek.com